Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians

Diabetes, Obesity and Metabolism

Volumn 7, Issue 4, 2005, Pages 352-359

  Rosenbaum, Paulo ^a,f   Gimeno, S G A ^a   Sanudo, A ^a   Franco, L J ^b   Ferreira, S R G ^a   Osiro, K ^f   Iunes, M ^f   Matsumura, L K ^a   Moises, R C S ^a   de Barros Jr , N ^a   Hirai, A T ^a   Kikuchi, M ^c   Cardoso, M A ^b   Tomita, N ^c   Chaim, R ^d   Wakisaka, K ^e  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDADE DO SAGRADO CORAÇÃO   (Brazil)

^e Japanese Brazilian Study Center   (Brazil)

^f Japanese Brazilian Study Center ^*

Author keywords

Anthropometric parameters; Asians; Japanese Brazilians; Metabolic syndrome; Waist body mass index

Indexed keywords

ALBUMIN; CREATININE; INSULIN;

ADULT; AGE; ARTICLE; ASIAN; BODY MASS; BRAZIL; CARDIOVASCULAR RISK; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INSULIN RESISTANCE; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

EID: 21444442054     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00402.x     Document Type: Article

References (36)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutritional Examination Survey. JAMA 2002; 287: 356-359.
2. Ferreira SRG, Iunes M, Franco LJ, Iochida LC, Hirai A, Vivolo MA for the Japanese-Brazilian Diabetes Study Group. Disturbances of glucose and lipid metabolism in first and second generation Japanese-Brazilians. Diabetes Res Clin Pract 1996; 34 (Suppl.): S59-S63.
3. Ferreira SRG, Lerario DDG, Gimeno SGA, Sanudo A, Franco LJ for the Japanese-Brazilian Diabetes Study Group. Obesity and central adiposity in Japanese immigrants: role of the Western dietary pattern. J Epidemiol 2002; 12: 431-438.
4. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998; 20: 157-172.
5. Bouchard C. Genetics and the metabolic syndrome. Int J Obes Relat Metab Disord 1995; 19 (Suppl. 1): S52-S59.
6. American Association of Clinical Endocrinologists, American College of Endocrinology. ACE guidelines for glycemic control. Endocr Pract 2003; 9 (Suppl. 1): 7-19.
7. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: WHO Department of Noncommunicable Disease Surveillance, 1999.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
9. Steering Committee of the Western Pacific Region of the World Health Organization. The International Obesity Task Force (2000) The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne, Australia: Health Communications Australia Pty Limited. (retrieved from http://www.diabetes.com.au/research/report obesity.htm) (Accessed 11 April 2001).
10. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10-year observational follow-up study. Br Med J 1996; 313: 779-784.
11. Ljungman S, Wikstrand J, Hartford M, Berglun G. Urinary albumin excretion. A predictor of risk of cardiovascular disease - A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 1996; 9: 770-778.
12. Stehouer CDA, Nauta JJ, Zeldennrust GC, Hackeng WHL, Donker AJM, Ottolander DGJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-323.
13. Ferreira SRG, Iunes M, Franco LJ, Iochida LC, Hirai A, Vivolo MA for the Japanese-Brazilian Diabetes Study Group. Disturbances of glucose and lipid metabolism in first and second generation Japanese-Brazilians. Diabetes Res Clin Pract 1996; 34 (Suppl.): S59-S63.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
15. Novotny R, Davis J, Ross P, Wasnish R. Adiposity and blood pressure in a multiethnic population of women in Hawaii. Ethn Health 1998; 3: 167-173.
16. Deuremberg P, Yap M, Van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22: 1164-1171.
17. Pouliot M, Despres JP, Lemieux S et al. Waist circumference and abdominal saggital diameter: best simple anthropometric measures of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-468.
18. Lakka TA, Lakka HM, Salonen R, Kaplan GA, Salonen JT. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis 2001; 154 (2): 497-504.
19. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijav V. Metabolic syndrome in urban Asian Indians adults- a population study using modified ATP III criteria. Diabetes Res Clin Pract 2003; 60 (3): 199-204.
20. Examination Committee of Criteria for 'Obesity Disease in Japan'. Japan Society for Study Obesity. Circ J 2002; 66 (11): 987-992.
21. Gimeno SGA, Ferreira SRG, Franco LJ, Hirai A, Matsumura L, Moises RCS. Prevalence and 7-year incidence of type 2 diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia 2002; 45: 1635-1638.
22. Bonora E, Kiechl S, Willeit J et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck Study Diabetes Care 2003; 26: 1251-1257.
23. Lakka HM, Laaksonen DE, Laaka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
24. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-1077.
25. McNeely MJ, Boyko EJ, Shofer JB, Morris LN, Leonetti DL, Fujimoto WY. Standard definitions of overweight and central adiposity for determining diabetes risk in Japanese Americans. Am J Clin Nutr 2001; 74: 101-107.
26. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation: European Group for Study Insulin Resistance (EGIR). Diabet Med 1999; 16: 442-443.
27. Hodge AM, Dowse GK, Zimmet PZ. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med 1996; 13: 441-449.
28. Zavaroni I, Bonini L, Gasparini P et al. Dissociation between urinary albumin excretion and variables associates with insulin resistance in a healthy population. J Intern Med 1996; 240: 151-156.
29. Jager A, Kostense PJ, Nijpels G, Heine RJ, Boutner LM, Stehouwer CD. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: The Hoorn Study. Diabetologia 1998; 41: 694-700.
30. Giltay EJ, Hoogven EK, Elbers W, Gooren LJG, Asscheman H, Stehouer CDA. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 1998; 139: 197-198.
31. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001; 86: 713-718.
32. Frohlich M, Imhof A, Berg G et al. Association between C-reactive protein and features of the metabolic syndrome population-based study. Diabetes care 2000; 23: 1835-1839.
33. Nygard O, Nordrehaug JE, Refsum H et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236.
34. Anderson JL, Muhalstein JB, Horne BD et al. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 2000; 102: 1227-1232.
35. Abbasi F, Facchini F, Humphreys MH, Reaven GM. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 1999; 146: 175-178.
36. Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 2001; 86: 719-723.